Tarsus Pharmaceuticals Inc (TARS) — Cash Flow Reinvestment Rate
Tarsus Pharmaceuticals Inc (TARS) has a Cash Flow Reinvestment Rate of 0.69x as of June 2026, reinvesting $46.02 Million (capex $4.07 Million plus investments $41.95 Million) from operating cash flow of $66.77 Million. See TARS cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tarsus Pharmaceuticals Inc Cash Flow Reinvestment Rate (2021–2021)
Historical reinvestment intensity for Tarsus Pharmaceuticals Inc across 1 annual periods. For the full cash flow conversion analysis, see TARS cash flow metrics.
Annual Cash Flow Reinvestment Rate for Tarsus Pharmaceuticals Inc (2021–2021)
Year-by-year capital reinvestment analysis for Tarsus Pharmaceuticals Inc. See financial flexibility index of Tarsus Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.31x | $1.17 Million | $3.75 Million | $586.00K | — |